Format

Send to

Choose Destination
Vaccine. 1991 Feb;9(2):111-6.

Antibody assays suitable for assessing immune responses to live varicella vaccine.

Author information

1
Cellular and Molecular Biology, Merck Sharp & Dohme Research Laboratories, West Point, PA 19486.

Abstract

An enzyme-linked immunosorbent assay for antibodies to varicella-zoster virus (VZV), using purified viral glycoproteins as antigen (gpELISA), was compared with other assays for measuring vaccine-induced antibody responses. The gpELISA was more sensitive than conventional assays, proved highly specific for VZV and agreed well with an assay for neutralizing antibody activity. It was successfully applied to large-scale testing of live varicella vaccine in humans.

PMID:
1647574
DOI:
10.1016/0264-410x(91)90266-9
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center